▶ 調査レポート

核医学画像システムの世界市場見通し2023年-2029年

• 英文タイトル:Nuclear Medicine Imaging System Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが調査・発行した産業分析レポートです。核医学画像システムの世界市場見通し2023年-2029年 / Nuclear Medicine Imaging System Market, Global Outlook and Forecast 2023-2029 / MRC2312MG07788資料のイメージです。• レポートコード:MRC2312MG07788
• 出版社/出版日:Market Monitor Global / 2023年12月
• レポート形態:英文、PDF、61ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥481,000 (USD3,250)▷ お問い合わせ
  Enterprise User¥721,500 (USD4,875)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートは次の情報を含め、世界の核医学画像システム市場規模と予測を収録しています。・世界の核医学画像システム市場:売上、2018年-2023年、2024年-2029年
・世界の核医学画像システム市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の核医学画像システム市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「PET」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

核医学画像システムのグローバル主要企業は、GE Healthcare、 Siemens Healthineers、 Mediso、 Spectrum Dynamics、 Bruker、 SurgicEye、 MIE、 MILabs、 Topgrade HealthCareなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、核医学画像システムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の核医学画像システム市場:タイプ別、2018年-2023年、2024年-2029年
世界の核医学画像システム市場:タイプ別市場シェア、2022年
・PET、 SPECT

世界の核医学画像システム市場:用途別、2018年-2023年、2024年-2029年
世界の核医学画像システム市場:用途別市場シェア、2022年
・病院、第三者画像センター、その他

世界の核医学画像システム市場:地域・国別、2018年-2023年、2024年-2029年
世界の核医学画像システム市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における核医学画像システムのグローバル売上、2018年-2023年
・主要企業における核医学画像システムのグローバル売上シェア、2022年
・主要企業における核医学画像システムのグローバル販売量、2018年-2023年
・主要企業における核医学画像システムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GE Healthcare、 Siemens Healthineers、 Mediso、 Spectrum Dynamics、 Bruker、 SurgicEye、 MIE、 MILabs、 Topgrade HealthCare

*************************************************************

・調査・分析レポートの概要
核医学画像システム市場の定義
市場セグメント
世界の核医学画像システム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の核医学画像システム市場規模
世界の核医学画像システム市場規模:2022年 VS 2029年
世界の核医学画像システム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの核医学画像システムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の核医学画像システム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:PET、 SPECT
核医学画像システムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、第三者画像センター、その他
核医学画像システムの用途別グローバル売上・予測

・地域別市場分析
地域別核医学画像システム市場規模 2022年と2029年
地域別核医学画像システム売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
GE Healthcare、 Siemens Healthineers、 Mediso、 Spectrum Dynamics、 Bruker、 SurgicEye、 MIE、 MILabs、 Topgrade HealthCare
...

This research report provides a comprehensive analysis of the Nuclear Medicine Imaging System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nuclear Medicine Imaging System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nuclear Medicine Imaging System, challenges faced by the industry, and potential opportunities for market players.
The global Nuclear Medicine Imaging System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nuclear Medicine Imaging System market presents opportunities for various stakeholders, including Hospital, Third-party Imaging Center. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nuclear Medicine Imaging System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nuclear Medicine Imaging System market was valued at US$ 2554.1 million in 2022 and is projected to reach US$ 4392.4 million by 2029, at a CAGR of 7.8% during the forecast period.
Technological Advancements: Continuous advancements in nuclear medicine imaging technology, including improved detectors, software algorithms, and image processing techniques, were enhancing image quality, reducing radiation exposure, and increasing diagnostic accuracy.
Hybrid Imaging: The integration of nuclear medicine imaging with other imaging modalities, such as positron emission tomography-computed tomography (PET-CT) and single-photon emission computed tomography-computed tomography (SPECT-CT), was gaining popularity. These hybrid systems provided comprehensive anatomical and functional information in a single scan.
Theranostics: Theranostics, which involves using nuclear medicine for both diagnosis and therapy, was a growing trend. Radiopharmaceuticals were being developed and used to treat various diseases, including cancer and neuroendocrine tumors.
Personalized Medicine: Nuclear medicine imaging played a vital role in personalized medicine by tailoring treatments based on an individual’s unique characteristics, such as genetics and molecular markers. This trend was particularly notable in oncology.
Key Features:
The research report on the Nuclear Medicine Imaging System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nuclear Medicine Imaging System market.
Market Overview: The report provides a comprehensive overview of the Nuclear Medicine Imaging System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., PET, SPECT), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nuclear Medicine Imaging System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nuclear Medicine Imaging System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nuclear Medicine Imaging System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nuclear Medicine Imaging System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nuclear Medicine Imaging System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nuclear Medicine Imaging System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nuclear Medicine Imaging System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nuclear Medicine Imaging System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nuclear Medicine Imaging System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
PET
SPECT
Market segment by Application
Hospital
Third-party Imaging Center
Other
Global Nuclear Medicine Imaging System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GE Healthcare
Siemens Healthineers
Mediso
Spectrum Dynamics
Bruker
SurgicEye
MIE
MILabs
Topgrade HealthCare
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nuclear Medicine Imaging System, market overview.
Chapter 2: Global Nuclear Medicine Imaging System market size in revenue.
Chapter 3: Detailed analysis of Nuclear Medicine Imaging System company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nuclear Medicine Imaging System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine Imaging System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine Imaging System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine Imaging System Overall Market Size
2.1 Global Nuclear Medicine Imaging System Market Size: 2022 VS 2029
2.2 Global Nuclear Medicine Imaging System Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nuclear Medicine Imaging System Players in Global Market
3.2 Top Global Nuclear Medicine Imaging System Companies Ranked by Revenue
3.3 Global Nuclear Medicine Imaging System Revenue by Companies
3.4 Top 3 and Top 5 Nuclear Medicine Imaging System Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nuclear Medicine Imaging System Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nuclear Medicine Imaging System Players in Global Market
3.6.1 List of Global Tier 1 Nuclear Medicine Imaging System Companies
3.6.2 List of Global Tier 2 and Tier 3 Nuclear Medicine Imaging System Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Nuclear Medicine Imaging System Market Size Markets, 2022 & 2029
4.1.2 PET
4.1.3 SPECT
4.2 By Type – Global Nuclear Medicine Imaging System Revenue & Forecasts
4.2.1 By Type – Global Nuclear Medicine Imaging System Revenue, 2018-2023
4.2.2 By Type – Global Nuclear Medicine Imaging System Revenue, 2024-2029
4.2.3 By Type – Global Nuclear Medicine Imaging System Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nuclear Medicine Imaging System Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-party Imaging Center
5.1.4 Other
5.2 By Application – Global Nuclear Medicine Imaging System Revenue & Forecasts
5.2.1 By Application – Global Nuclear Medicine Imaging System Revenue, 2018-2023
5.2.2 By Application – Global Nuclear Medicine Imaging System Revenue, 2024-2029
5.2.3 By Application – Global Nuclear Medicine Imaging System Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Nuclear Medicine Imaging System Market Size, 2022 & 2029
6.2 By Region – Global Nuclear Medicine Imaging System Revenue & Forecasts
6.2.1 By Region – Global Nuclear Medicine Imaging System Revenue, 2018-2023
6.2.2 By Region – Global Nuclear Medicine Imaging System Revenue, 2024-2029
6.2.3 By Region – Global Nuclear Medicine Imaging System Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Nuclear Medicine Imaging System Revenue, 2018-2029
6.3.2 US Nuclear Medicine Imaging System Market Size, 2018-2029
6.3.3 Canada Nuclear Medicine Imaging System Market Size, 2018-2029
6.3.4 Mexico Nuclear Medicine Imaging System Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Nuclear Medicine Imaging System Revenue, 2018-2029
6.4.2 Germany Nuclear Medicine Imaging System Market Size, 2018-2029
6.4.3 France Nuclear Medicine Imaging System Market Size, 2018-2029
6.4.4 U.K. Nuclear Medicine Imaging System Market Size, 2018-2029
6.4.5 Italy Nuclear Medicine Imaging System Market Size, 2018-2029
6.4.6 Russia Nuclear Medicine Imaging System Market Size, 2018-2029
6.4.7 Nordic Countries Nuclear Medicine Imaging System Market Size, 2018-2029
6.4.8 Benelux Nuclear Medicine Imaging System Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Nuclear Medicine Imaging System Revenue, 2018-2029
6.5.2 China Nuclear Medicine Imaging System Market Size, 2018-2029
6.5.3 Japan Nuclear Medicine Imaging System Market Size, 2018-2029
6.5.4 South Korea Nuclear Medicine Imaging System Market Size, 2018-2029
6.5.5 Southeast Asia Nuclear Medicine Imaging System Market Size, 2018-2029
6.5.6 India Nuclear Medicine Imaging System Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Nuclear Medicine Imaging System Revenue, 2018-2029
6.6.2 Brazil Nuclear Medicine Imaging System Market Size, 2018-2029
6.6.3 Argentina Nuclear Medicine Imaging System Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Nuclear Medicine Imaging System Revenue, 2018-2029
6.7.2 Turkey Nuclear Medicine Imaging System Market Size, 2018-2029
6.7.3 Israel Nuclear Medicine Imaging System Market Size, 2018-2029
6.7.4 Saudi Arabia Nuclear Medicine Imaging System Market Size, 2018-2029
6.7.5 UAE Nuclear Medicine Imaging System Market Size, 2018-2029
7 Nuclear Medicine Imaging System Companies Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Nuclear Medicine Imaging System Major Product Offerings
7.1.4 GE Healthcare Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.1.5 GE Healthcare Key News & Latest Developments
7.2 Siemens Healthineers
7.2.1 Siemens Healthineers Company Summary
7.2.2 Siemens Healthineers Business Overview
7.2.3 Siemens Healthineers Nuclear Medicine Imaging System Major Product Offerings
7.2.4 Siemens Healthineers Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.2.5 Siemens Healthineers Key News & Latest Developments
7.3 Mediso
7.3.1 Mediso Company Summary
7.3.2 Mediso Business Overview
7.3.3 Mediso Nuclear Medicine Imaging System Major Product Offerings
7.3.4 Mediso Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.3.5 Mediso Key News & Latest Developments
7.4 Spectrum Dynamics
7.4.1 Spectrum Dynamics Company Summary
7.4.2 Spectrum Dynamics Business Overview
7.4.3 Spectrum Dynamics Nuclear Medicine Imaging System Major Product Offerings
7.4.4 Spectrum Dynamics Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.4.5 Spectrum Dynamics Key News & Latest Developments
7.5 Bruker
7.5.1 Bruker Company Summary
7.5.2 Bruker Business Overview
7.5.3 Bruker Nuclear Medicine Imaging System Major Product Offerings
7.5.4 Bruker Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.5.5 Bruker Key News & Latest Developments
7.6 SurgicEye
7.6.1 SurgicEye Company Summary
7.6.2 SurgicEye Business Overview
7.6.3 SurgicEye Nuclear Medicine Imaging System Major Product Offerings
7.6.4 SurgicEye Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.6.5 SurgicEye Key News & Latest Developments
7.7 MIE
7.7.1 MIE Company Summary
7.7.2 MIE Business Overview
7.7.3 MIE Nuclear Medicine Imaging System Major Product Offerings
7.7.4 MIE Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.7.5 MIE Key News & Latest Developments
7.8 MILabs
7.8.1 MILabs Company Summary
7.8.2 MILabs Business Overview
7.8.3 MILabs Nuclear Medicine Imaging System Major Product Offerings
7.8.4 MILabs Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.8.5 MILabs Key News & Latest Developments
7.9 Topgrade HealthCare
7.9.1 Topgrade HealthCare Company Summary
7.9.2 Topgrade HealthCare Business Overview
7.9.3 Topgrade HealthCare Nuclear Medicine Imaging System Major Product Offerings
7.9.4 Topgrade HealthCare Nuclear Medicine Imaging System Revenue in Global Market (2018-2023)
7.9.5 Topgrade HealthCare Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer